According to Neuren Pharmaceuticals's latest financial reports the company's total liabilities are โน2.52 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | โน2.42 B | 2466.81% |
2022-12-31 | โน94.49 M | 118.07% |
2021-12-31 | โน43.33 M | 2.33% |
2020-12-31 | โน42.34 M | 51.72% |
2019-12-31 | โน27.9 M | -71.28% |
2018-12-31 | โน97.18 M | 23.4% |
2017-12-31 | โน78.76 M | -20.68% |
2016-12-31 | โน99.28 M | -18.03% |
2015-12-31 | โน0.12 B | -22.88% |
2014-12-31 | โน0.15 B | 38.48% |
2013-12-31 | โน0.11 B | -6.92% |
2012-12-31 | โน0.12 B | 33.44% |
2011-12-31 | โน91.31 M | -8.12% |
2010-12-31 | โน99.38 M | -18.8% |
2009-12-31 | โน0.12 B | 21.46% |
2008-12-31 | โน0.10 B | -58.25% |
2007-12-31 | โน0.24 B | 104.72% |
2006-12-31 | โน0.11 B | 17.57% |
2005-12-31 | โน0.10 B | -28.68% |
2004-12-31 | โน0.14 B | |
2003-12-31 | N/A | |
2002-12-31 | N/A |